Synergistic antileukemic activity of combinations of two nitrosoureas. 1981

G P Wheeler, and F M Schabel, and M W Trader

A rationale based on known chemical, biochemical, and biologic properties of nitrosoureas led to the testing of combinations of CCNU with chlorozotocin for in vivo activity against L1210 leukemia. Several combinations yielded synergistic antileukemic activity.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008130 Lomustine An alkylating agent of value against both hematologic malignancies and solid tumors. CCNU,Belustine,Cecenu,CeeNU,NSC-79037,NSC 79037,NSC79037
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013311 Streptozocin An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals. Streptozotocin,2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucose,Streptozotocine,Zanosar
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

G P Wheeler, and F M Schabel, and M W Trader
May 1972, Cancer chemotherapy reports. Part 3,
G P Wheeler, and F M Schabel, and M W Trader
December 2016, International journal of antimicrobial agents,
G P Wheeler, and F M Schabel, and M W Trader
October 1973, Biochemical and biophysical research communications,
G P Wheeler, and F M Schabel, and M W Trader
October 2018, Antimicrobial agents and chemotherapy,
G P Wheeler, and F M Schabel, and M W Trader
May 2012, Tuberculosis (Edinburgh, Scotland),
G P Wheeler, and F M Schabel, and M W Trader
January 1985, Investigational new drugs,
G P Wheeler, and F M Schabel, and M W Trader
March 1986, International journal of cancer,
G P Wheeler, and F M Schabel, and M W Trader
April 2022, Nature reviews. Drug discovery,
G P Wheeler, and F M Schabel, and M W Trader
November 2015, Nature chemical biology,
G P Wheeler, and F M Schabel, and M W Trader
January 2021, Pakistan journal of biological sciences : PJBS,
Copied contents to your clipboard!